Page 116 - 《中国药房》2024年13期
P. 116

[21]  BAKHSHIMOGHADDAM F,SHATERI K,SINA M,et             Bifidobacterium  longum  with  fructo-oligosaccharides  in
               al. Daily consumption of synbiotic yogurt decreases liver   patients with non alcoholic steatohepatitis[J]. Dig Dis Sci,
               steatosis in patients with nonalcoholic fatty liver disease:a   2012,57(2):545-553.
               randomized  controlled  clinical  trial[J].  J  Nutr,2018,148  [31]  BARCELOS S T A,SILVA-SPERB A S,MORAES H A,
              (8):1276-1284.                                       et al. Oral 24-week probiotics supplementation did not de‐
          [22]  ASGHARIAN  A,ASKARI  G,ESMAILZADE  A,et  al.       crease cardiovascular risk markers in patients with biopsy
               The  effect  of  symbiotic  supplementation  on  liver  en‐  proven  NASH:a  double-blind  placebo-controlled  rando-
               zymes,C-reactive  protein  and  ultrasound  findings  in  pa‐  mized study[J]. Ann Hepatol,2022,27(9):100769.
               tients with non-alcoholic fatty liver disease:a clinical trial  [32]  ESCOUTO G S,PORT G Z,TOVO C V,et al. Probiotic
               [J]. Int J Prev Med,2016,7:59.                      supplementation,hepatic fibrosis,and the microbiota pro‐
          [23]  EKHLASI G,KOLAHDOUZ MOHAMMADI R,AGAH               file  in  patients  with  nonalcoholic  steatohepatitis:a  ran‐
               S,et  al.  Do  symbiotic  and  vitamin  E  supplementation   domized controlled trial[J]. J Nutr,2023,153(7):1984-
               have favorite effects in nonalcoholic fatty liver disease:a   1993.
               randomized,double-blind,placebo-controlled  trial[J].  J   [33]  ABDEL MONEM S M. Probiotic therapy in patients with
               Res Med Sci,2016,21:106.                            nonalcoholic  steatohepatitis  in  Zagazig  University  hospi‐
          [24]  NABAVI  S,RAFRAF  M,SOMI  M  H,et  al.  Effects  of   tals[J].  Euroasian  J  Hepatogastroenterol,2017,7(1):
               probiotic yogurt consumption on metabolic factors in indi‐  101-106.
               viduals  with  nonalcoholic  fatty  liver  disease[J].  J  Dairy   [34]  ABHARI K,SAADATI S,YARI Z,et al. The effects of
               Sci,2014,97(12):7386-7393.                          Bacillus coagulans supplementation in patients with non-
          [25]  ALLER R,DE LUIS D A,IZAOLA O,et al. Effect of a    alcoholic  fatty  liver  disease:a  randomized,placebo-
               probiotic on liver aminotransferases in nonalcoholic fatty   controlled,clinical  trial[J].  Clin  Nutr  ESPEN,2020,39:
               liver disease patients:a double blind randomized clinical   53-60.
               trial[J]. Eur Rev Med Pharmacol Sci,2011,15(9):1090-  [35]  SALMINEN S,COLLADO M C,ENDO A,et al. The In‐
               1095.                                               ternational Scientific Association of Probiotics and Prebi‐
          [26]  姜艳艳. 肠道益生菌治疗非酒精性脂肪肝的效果及对肝                          otics (ISAPP) consensus statement on the definition and
               功能、炎性因子的影响[J]. 临床合理用药杂志,2020,13                     scope  of  postbiotics[J].  Nat  Rev  Gastroenterol  Hepatol,
              (8):26-27.                                           2021,18(9):649-667.
               JIANG Y Y. Effect of intestinal probiotics on nonalcoholic   [36]  MIJANGOS-TREJO A,NUÑO-LAMBARRI N,BARBERO-
               fatty liver and its influence on liver function and inflam‐  BECERRA V,et al. Prebiotics and probiotics:therapeutic
               matory factors[J]. Chin J Clin Ration Drug Use,2020,13  tools for nonalcoholic fatty liver disease[J]. Int J Mol Sci,
              (8):26-27.                                           2023,24(19):14918.
          [27]  郑丹,吴江,甘洪颖,等. 双歧杆菌三联活菌胶囊治疗非                    [37]  SALTZMAN E T,PALACIOS T,THOMSEN M,et al. In‐
               酒精性脂肪肝的临床观察[J]. 临床消化病杂志,2018,30                     testinal  microbiome  shifts,dysbiosis,inflammation,and
              (4):240-243.                                         non-alcoholic  fatty  liver  disease[J].  Front  Microbiol,
               ZHENG D,WU J,GAN H Y,et al. Clinical study of pro‐  2018,9:61.
               biotics for non-alcoholic fatty liver disease[J]. Chin J Clin   [38]  高明月,杨雅坤,殷雅楠,等. 肠道菌群介导的非酒精性
               Gastroenterol,2018,30(4):240-243.                   脂肪性肝病发病机制研究进展[J]. 解放军医学杂志,
          [28]  赵庆卫,吕道仙. 益生菌对非酒精性脂肪性肝病的干预                          2020,45(9):990-995.
               作用[J]. 中国现代医生,2016,54(8):29-33.                     GAO  M  Y,YANG  Y  K,YIN  Y  N,et  al.  Research  ad‐
               ZHAO Q W,LYU D X. Probiotics for non-alcoholic fatty   vances in the pathogenesis of non-alcoholic fatty liver me‐
               liver disease intervention effect[J]. China Mod Dr,2016,  diated by intestinal flora[J]. Med J Chin People’s Libera‐
               54(8):29-33.                                        tion Army,2020,45(9):990-995.
          [29]  JAVADI L,KHOSHBATEN M,SAFAIYAN A,et al. Pro-   [39]  ZHOU X Y,WANG J C,ZHOU S F,et al. Efficacy of pro‐
               and prebiotic effects on oxidative stress and inflammatory   biotics on nonalcoholic fatty liver disease:a meta-analysis
               markers in non-alcoholic fatty liver disease[J]. Asia Pac J   [J]. Medicine (Baltimore),2023,102(4):e32734.
               Clin Nutr,2018,27(5):1031-1039.                              (收稿日期:2023-11-08  修回日期:2024-04-02)
          [30]  MALAGUARNERA M,VACANTE M,ANTIC T,et al.                                           (编辑:刘明伟)





          · 1650 ·    China Pharmacy  2024 Vol. 35  No. 13                            中国药房  2024年第35卷第13期
   111   112   113   114   115   116   117   118   119   120   121